“national-cancer-institute” Archives

in
Entry Author Date Location
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies 05/28/20 National
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
AstraZeneca Wins First FDA Drug Nod for NF1, a Rare Genetic Disorder 04/10/20 National
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
After Brain Cancer Drug Fails, Tocagen to Cut More Than Half of Staff 10/03/19 San Diego
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy 02/20/19 Texas
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
A.I. Prizes, Coming to Healthcare, Hit $1M Mark in Cancer Contests 07/20/17 National
Around Texas: Joseph Kopser, Mark Cuban, REVtech, Founder Institute 05/24/17 Texas
UT Health San Antonio Lands $9.1M Grant to Study Drug Resistance 05/16/17 Texas
WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug 03/10/17 Wisconsin
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future 02/21/17 Wisconsin
Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs 02/13/17 Wisconsin
Cellectar Awarded Another Cancer Drug Patent 01/26/17 Wisconsin
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Hyperloop, Epic, Wantable, & More: This Week’s Wisconsin Watchlist 12/09/16 Wisconsin
Medical Imaging Startup OnLume Seeks to Show Surgeons The Light 12/06/16 Wisconsin
Cellectar Advances Drug Research With Pierre Fabre, Other Partners 11/18/16 Wisconsin
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist 11/08/16 Wisconsin
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
Page 1 of 4 next page »